Regeneron Pharmaceuticals, Inc. (REGN)
852.29
+28.47
(+3.46%)
USD |
NASDAQ |
Sep 02, 16:00
850.01
-2.28
(-0.27%)
After-Hours: 19:06
Regeneron Pharmaceuticals Cash from Operations (Annual) : 4.979B for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 4.979B |
| December 31, 2024 | 4.420B |
| December 31, 2023 | 4.594B |
| December 31, 2022 | 5.015B |
| December 31, 2021 | 7.081B |
| December 31, 2020 | 2.618B |
| December 31, 2019 | 2.43B |
| December 31, 2018 | 2.195B |
| December 31, 2017 | 1.307B |
| December 31, 2016 | 1.473B |
| December 31, 2015 | 1.331B |
| December 31, 2014 | 743.16M |
| December 31, 2013 | 583.65M |
| December 31, 2012 | -74.62M |
| December 31, 2011 | -141.68M |
| December 31, 2010 | 96.34M |
| December 31, 2009 | -72.23M |
| December 31, 2008 | -89.09M |
| Date | Value |
|---|---|
| December 31, 2007 | 27.37M |
| December 31, 2006 | 23.08M |
| December 31, 2005 | -30.30M |
| December 31, 2004 | -16.91M |
| December 31, 2003 | -6.133M |
| December 31, 2002 | -110.52M |
| December 31, 2001 | -57.32M |
| December 31, 2000 | -27.91M |
| December 31, 1999 | -13.84M |
| December 31, 1998 | -10.20M |
| December 31, 1997 | -6.078M |
| December 31, 1996 | -20.28M |
| December 31, 1995 | -4.817M |
| December 31, 1994 | -9.300M |
| December 31, 1993 | -30.14M |
| December 31, 1992 | -17.17M |
| December 31, 1991 | -6.811M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 524.08M |
| AbbVie, Inc. | 19.03B |
| Gilead Sciences, Inc. | 10.02B |
| Amgen, Inc. | 9.958B |
| Biogen, Inc. | 2.205B |